Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 21, 2021

View Archived Issues

Hongyun Biotech identifies new EGFR inhibitors

New ATR kinase inhibitors discovered at Shenzhen Life Fountain Biotech

Researchers unveil ACOT13, PTGER2 as candidate genes of autosomal dominant polycystic kidney disease

GTPase KRAS mutant inhibitors patented by Genfleet Therapeutics

Biopolar Hongye presents new Janus kinase inhibitors

JAK inhibitors divulged by Jiangsu Hansoh Pharmaceutical, Shanghai Hansoh Biomedical

CLIP-170S confers resistance to taxane-based therapy in gastric cancer

IpY.20 targets p27Kip1 to evade breast cancer resistance driven by CDK4 and CDK2

MCC-1734 inhibits cancer cells with different resistance mechanisms

Mouse model of metaplastic breast cancer with conditional overexpression of TRIM24

Novel XO inhibitors show efficacy in acute hyperuricemia rat model

P38 targeting reverses immunosuppressive tumor microenvironment in metastatic breast cancer

FibroGen exercises license option for HiFiBiO's anti-CCR8 monoclonal antibody program

IFI27 as a potential new gene biomarker for severe COVID-19

Aridis' AR-701 is broadly reactive against Omicron and other SARS-CoV-2 variants

RaQualia and Hisamitsu to enter license agreement for sodium channel blocker

Choline transporter in fruit fly brain tunes out unnecessary information

Extension of Series A financing at Ambys supports progression of AMI-918 for liver disease

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for December 24, 2024.
Enhanced Cognition: Lewy body dementia phase II pumps stock
BioWorld
Investors will get more details during the International Lewy Body Dementia Conference in Amsterdam late next month, but Wall Street is already buzzing about...
Experimental mRNA gene therapy suppresses preeclampsia in mice
BioWorld MedTech
A gene therapy based on an enhanced lipid nanoparticle (LNP) loaded with vascular endothelial growth factor (VEGF) mRNA could be developed for the treatment of...
Drug duo to Repare lack in gyno cancers? Phase I shows promise
BioWorld
Wall Street wasn’t jumping up and down about Repare Therapeutics Inc.’s early data in gynecological cancers, though the findings look positive and the company has...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.